To determine if systemic IL-5 over-expression alters pulmonary metastatic tumor growth, we utilized an experimental model of pulmonary metastasis by injecting EO771 mammary carcinoma cells intravenously (i.v.)to directly seed the lung tissue and harvested lungs for analysis 21 days following i.v. injection. This evidence concerns the gene IL5 and breast carcinoma.